Transitional Pain Service for patients at Risk of chronic postsurgical pain Undergoing Surgery

Amsterdam University Medical Center, location Meibergdreef (AMC)0 个研究点目标入组 176 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Patients aged 18 years or older
•2.Willing and able to provide informed consent
•3.Undergoing a surgical procedure with an increased risk of CPSP (amputation, spinal surgery, thoracotomy, breast surgery, herniotomy, hysterectomy and after arthroplasty) (9).
•Any surgical procedure and one of the following:
•-Diagnosed chronic pain, defined according to the ICD-11 as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Chronic pain is pain that persists or recurs for longer than 3 months (3)”
•-Chronic opioid use, defined as > 20 mg daily morphine equivalent (MME) consumption for more than 3 months in the last 3 months
•-Allergy to opioid agents
•-Patients with pain device implants, such as intrathecal pain pump, spinal cord stimulation or peripheral nerve stimulator
•-The usage of pain medication as methadone, buprenorphine, anticonvulsants, antidepressants or medicinal cannabis for chronic pain for more than 3 months in the last three months
•- Psychosocial comorbidities like anxiety, depression, pain catastrophizing if documented in the electronic medical record

•- Patients who undergo emergency surgery are excluded to ensure sufficient time for the informed consent process.
•- Patients undergoing implementation of pain device implants, such as intrathecal pain pump, spinal cord stimulators or peripheral nerve stimulator.
•- Patients who undergo surgery that most likely leads to prolonged sedation and for that reason cannot fill in the QoR-15 questionnaire at day three postoperative.

发起方

Amsterdam University Medical Center, location Meibergdreef (AMC)